DOI: 10.1055/s-00000025

Hormone and Metabolic Research

References

Nissen SE, Wolski K, Topol EJ.
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus. 
JAMA 2005; 294: 2581-2586  

Download Bibliographical Data

Access:
Access:
Access: